Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer

Yanting Lin(China Pharmaceutical University), Dongquan Jing(China Pharmaceutical University), Qiuhua Cao(China Pharmaceutical University), Siliang Liu(China Pharmaceutical University), Yali Su(China Pharmaceutical University), Beiying Dai(China Pharmaceutical University), Ran Bi(Jilin University), Xinmeng Cui(China Pharmaceutical University), Mingrui Zhao(China Pharmaceutical University), Yiming Liu(China Pharmaceutical University), Anqi Chen(Macau University of Science and Technology), Xinghua Gao(Qilu Hospital of Shandong University), Zhenhua Gao(Shandong University), Rui Gao(China Pharmaceutical University), Qixiang Zhao(China Pharmaceutical University), Yong Yang(South China University of Technology)
European Journal of Pharmacology
April 11, 2023
Cited by 38


Related Papers